These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
483 related items for PubMed ID: 15096402
1. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis. De Stefano N, Bartolozzi ML, Nacmias B, Zipoli V, Mortilla M, Guidi L, Siracusa G, Sorbi S, Federico A, Amato MP. Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402 [Abstract] [Full Text] [Related]
2. APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis. Portaccio E, Goretti B, Zipoli V, Nacmias B, Stromillo ML, Bartolozzi ML, Siracusa G, Guidi L, Federico A, Sorbi S, De Stefano N, Amato MP. Mult Scler; 2009 Dec; 15(12):1489-94. PubMed ID: 19965518 [Abstract] [Full Text] [Related]
3. Apolipoprotein genotype does not influence MS severity, cognition, or brain atrophy. van der Walt A, Stankovich J, Bahlo M, Taylor BV, van der Mei IA, Foote SJ, Kilpatrick TJ, Rubio JP, Butzkueven H. Neurology; 2009 Sep 29; 73(13):1018-25. PubMed ID: 19786693 [Abstract] [Full Text] [Related]
4. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Di Perri C, Battaglini M, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N. Arch Neurol; 2008 Feb 29; 65(2):236-43. PubMed ID: 18268194 [Abstract] [Full Text] [Related]
6. Anatomically-distinct genetic associations of APOE epsilon4 allele load with regional cortical atrophy in Alzheimer's disease. Filippini N, Rao A, Wetten S, Gibson RA, Borrie M, Guzman D, Kertesz A, Loy-English I, Williams J, Nichols T, Whitcher B, Matthews PM. Neuroimage; 2009 Feb 01; 44(3):724-8. PubMed ID: 19013250 [Abstract] [Full Text] [Related]
7. [The absence of a relation between apolipoprotein E genotypes and the severity of multiple sclerosis in Mexican patients]. Corona T, Guerrero-Camacho JL, Alonso-Vilatela ME, Flores-Rivera Jde J. Rev Neurol; 2009 Feb 01; 50(1):19-22. PubMed ID: 20073019 [Abstract] [Full Text] [Related]
8. In-vivo evidence for stable neuroaxonal damage in the brain of patients with benign multiple sclerosis. Benedetti B, Rovaris M, Rocca MA, Caputo D, Zaffaroni M, Capra R, Bertolotto A, Martinelli V, Comi G, Filippi M. Mult Scler; 2009 Jul 01; 15(7):789-94. PubMed ID: 19465450 [Abstract] [Full Text] [Related]
9. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele. Sunderland T, Mirza N, Putnam KT, Linker G, Bhupali D, Durham R, Soares H, Kimmel L, Friedman D, Bergeson J, Csako G, Levy JA, Bartko JJ, Cohen RM. Biol Psychiatry; 2004 Nov 01; 56(9):670-6. PubMed ID: 15522251 [Abstract] [Full Text] [Related]
11. Determinants of disability in multiple sclerosis at various disease stages: a multiparametric magnetic resonance study. Pulizzi A, Rovaris M, Judica E, Sormani MP, Martinelli V, Comi G, Filippi M. Arch Neurol; 2007 Aug 01; 64(8):1163-8. PubMed ID: 17698707 [Abstract] [Full Text] [Related]
16. Brain damage as detected by magnetization transfer imaging is less pronounced in benign than in early relapsing multiple sclerosis. De Stefano N, Battaglini M, Stromillo ML, Zipoli V, Bartolozzi ML, Guidi L, Siracusa G, Portaccio E, Giorgio A, Sorbi S, Federico A, Amato MP. Brain; 2006 Aug 09; 129(Pt 8):2008-16. PubMed ID: 16815879 [Abstract] [Full Text] [Related]
17. Orbitofrontal cortex volume in late life depression: influence of hyperintense lesions and genetic polymorphisms. Taylor WD, Macfall JR, Payne ME, McQuoid DR, Steffens DC, Provenzale JM, Krishnan KR. Psychol Med; 2007 Dec 09; 37(12):1763-73. PubMed ID: 17335636 [Abstract] [Full Text] [Related]